Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiological Response to Indacaterol + Mometasone in Exercise
NCT06067100Recruiting
- Start
- Jan 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of indacaterol in asthma (3 arms). Primary endpoint: Power output during sprint testing. Started Jan 2024; status: recruiting.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06067100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06067100.